A pivotal 2021 clinical trial of semaglutide showed that participants lost an average of 15% of their body weight over 68 weeks, compared to just 2% in the placebo group
The Gut-Brain Axis and Emotional Eating GLP-1 impacts the gut-brain axis an intricate communication system between the gut microbiota and brain via neural, immune and hormonal signalling (Singh et al, 2024)
Melhoria da Sade Intestinal: Ao alimentar seletivamente as bactrias benficas, os prebiticos contribuem para a manuteno de um ambiente intestinal saudvel
Both share GI side effects like nausea, vomiting, and diarrhea that ease over time
Income-based patient assistance programs Both manufacturers offer Patient Assistance Programs (PAPs) that provide medications at no cost to qualifying individuals
Comprehensive Clinical support GLP-1s are only considered within the context of whole-person care